TJX Companies (TJX)
NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-10-29
$141.39+2.17%
Close 2026-10-29 · 1-day change
NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-10-29
Research Workspace
Put TJX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Apparel Retail is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 47% growth a year, above the roughly 7% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskTJX's steady performance supports the thesis, though revenue growth has slowed from 9% to 5%. Its latest quarter still beat earnings expectations, with revenue up 5% year over year. TJX trades at 27× P/E versus a 16× peer median, near its 29× historical multiple. The market is pricing in more growth than our forecast. Customer concerns and weakening comparable sales threaten the FY27 growth objective. Our model puts the next-quarter miss probability near 20%. Peer multiples imply a price about 47% below where it trades; our read remains intact, and this read is provisional.
Trailing returns as of 2026-10-29. TJX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 23 analysts currently covering TJX (as of Oct 2026).
Based on 8 Wall Street analysts offering 12-month price targets for TJX in the last 4 months.
Continue this research
Compare TJX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| TJX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Apparel Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put TJX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Increase full year FY27 comp sales growth to 3% to 4%
Customer issues could hinder comp sales growth objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $141.39
The last 12 months of price, then the range of analyst 12-month targets from today’s $141.39.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Increase full year FY27 comp sales growth to 3% to 4%
Weakening comps could hinder sales growth objectives.
New board member may enhance strategic direction.
Store closures may hinder comp sales growth objectives.
Threatens: Increase full year FY27 comp sales growth to 3% to 4%
Stock decline indicates potential risks to sales growth.
Advances: Increase pretax profit margin outlook to 12.0% to 12.1% for FY27
Improved margin outlook supports profit margin objective.
Advances: Increase full year FY27 comp sales growth to 3% to 4%
Beating expectations supports comp sales growth objective.
Threatens: Increase full year FY27 comp sales growth to 3% to 4%
Downgrade indicates potential slowdown in comp sales growth.
